K279-0810 Screening compound: N~1~-(2-METHOXYBENZYL)-3-[2-OXO-5-({2-OXO-2-[(TETRAHYDRO-2-FURANYLMETHYL)AMINO]ETHYL}SULFANYL)-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL]PROPANAMIDE

K279-0810 Screening compound: N~1~-(2-METHOXYBENZYL)-3-[2-OXO-5-({2-OXO-2-[(TETRAHYDRO-2-FURANYLMETHYL)AMINO]ETHYL}SULFANYL)-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL]PROPANAMIDE
K279-0810 Screening compound: N~1~-(2-METHOXYBENZYL)-3-[2-OXO-5-({2-OXO-2-[(TETRAHYDRO-2-FURANYLMETHYL)AMINO]ETHYL}SULFANYL)-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL]PROPANAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound K279-0810
N~1~-(2-METHOXYBENZYL)-3-[2-OXO-5-({2-OXO-2-[(TETRAHYDRO-2-FURANYLMETHYL)AMINO]ETHYL}SULFANYL)-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL]PROPANAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K279-0810

Molecular Formula

C28H31N5O5S (C28 H31 N5 O5 S)

Compound Name

N~1~-(2-METHOXYBENZYL)-3-[2-OXO-5-({2-OXO-2-[(TETRAHYDRO-2-FURANYLMETHYL)AMINO]ETHYL}SULFANYL)-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL]PROPANAMIDE

IUPAC name

n/a

SMILES

COc1c(CNC(CCC2N3C(SCC(NCC4OCCC4)=O)=Nc(cccc4)c4C3=NC2=O)=O)cccc1

InChI

InChI=1S/C28H31N5O5S/c1-37-23-11-5-2-7-18(23)15-29-24(34)13-12-22-27(36)32-26-20-9-3-4-10-21(20)31-28(33(22)26)39-17-25(35)30-16-19-8-6-14-38-19/h2-5,7,9-11,19,22H,6,8,12-17H2,1H3,(H,29,34)(H,30,35)

InChI Key

VCRPDEFVOOXTDZ-UHFFFAOYSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

549.65

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.426

Distribution Coefficient, logD

1.426

Water Solubility, LogSw

-2.38

Polar Surface Area

100.379

Acid Dissociation Constant (pKa)

10.29

Base Dissociation Constant (pKb)

3.90

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

39.30

K279-0810 in Drug Discovery

Included in Screening Libraries

Antiviral Annotated Library (21441 compounds)

Dark Chemical Matter Library (18430 compounds)

Eccentric PPI Library (11937 compounds)

Protein-Protein Interaction Library (218420 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Structure:
  • Pool
  • Cyclic compounds
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Receptor's ligands
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with K279-0810 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K279-0810?
Check Price and Availability of K279-0810, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K279-0810 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K279-0810
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K279-0810
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K279-0810 available by request